Abstract
Introduction: An acute stroke is a medical emergency that requires immediate attention to improve the patient's prognosis. We need to adequately identify the clinical manifestations, reduce care and management times, and lessen the associated disabilities.
Materials and methods: An observational, retrospective study using data from a hospital in Colombia from the RES-Q registry and the Angels initiative for the years 2021 and 2022.
Results: We registered 287 cases, with an average age of 67.85 years. The gender distribution was 51,92 % male and 48,08 % female. The predominant risk factors. The prevalence of arterial hypertension is 58,88 %, followed by diabetes at 57,49 %, hyperlipidemia at 5,22 %, and smoking at 3,48 %. Of these, 83.48 % have an ischemic origin, while 16.52% are hemorrhagic. The average time from the onset of symptoms to arrival at the service is 304.95 minutes, while the time from door-to-image is 53.02 minutes, and the time from door-to-needle is 66.50 minutes. We performed thrombolysis on 20.70 % of the ischemic events. We admitted 69.30 % of ischemic patients outside the window period, and 10 % did not meet the other criteria. 8.25 % of patients died.
Discussion: Advances in the treatment of stroke, where time is of the essence, continue to be in force, as time continues to be a determining variable in the outcome. Recent analyses have determined that door-to-needle time should be less than 30 minutes. The NIHSS scale helps to guide the diagnosis and decide on management.
Conclusions: It's clear that the care times fall short of the objectives; however, the goal is to enhance the actions and modify the process to shorten the duration of care, tailor the management according to the type of stroke, and avert future disabilities and sequelae that lower patients' quality of life.
References
Pigretti SG, Alet MJ, Mamani CE, Alonzo C, Aguilar M, Álvarez HJ, et al. Consenso sobre accidente cerebrovascular isquémico agudo. Medicina. 2019;79:1-46. http://www.scielo.org.ar/scielo.php?pid=S002576802019000400001&script=sci_arttext&tlng=en
Katan M, Luft A. Global burden of stroke. Semin Neurol. 2018;38(2):208-11. https://doi.org/10.1055/s-0038-1649503
Sequeiros-Chirinos JM, Alva-Díaz CA, Pacheco-Barrios K, Huaringa-Marcelo J, Huamaní C, Camarena-Flores CE, et al. Diagnosis and therapy for the acute stage of ischemic cerebrovascular accident: A clinical practice guideline from Peruvian Social Security (EsSalud). Acta Med Perú. 2020;37(1):54-73. https://doi.org/10.35663/amp.2020.371.869
Gonzales Piña R, Landinez Martínez D. Epidemiología, etiología y clasificación de la enfermedad vascular cerebral. Arch Med. 2016;16(2):495-507. https://pesquisa.bvsalud.org/portal/resource/pt/biblio-875163
Díaz-Mesa SA, Vásquez-Romero EM. Evolución de eventos cerebrovasculares isquémicos en pacientes tratados con trombolisis intravenosa en la unidad de ACV Dr. López Camacho de la Clínica Corominas, Santiago, República Dominicana, en el período de enero 2017-enero 2020 [disertación doctoral]. [Santo Domingo]: Universidad Iberoamericana (UNIBE); 2021. https://repositorio.unibe.edu.do/jspui/handle/123456789/573
Martinez Rubio CF, Rodríguez Orozco JE. Trombólisis endovenosa en ACV isquémico: experiencia en un hospital de Popayán, Cauca. Acta Neurol Colomb. 2020;36(3):212-4. https://doi.org/10.22379/24224022307
Martfnez-Villota VA, Bernal-Bastidas BL, Bernal-Bastidas WV, Miramag-Cánchala JA, Mera-Martínez PF, Cuenca-Valencia MF, et al. Calidad de la atención en salud en ataque cerebrovascular en un hospital de referencia en Colombia. Acta Neurol Colomb. 2022;38(1):2-11. https://doi.org/10.22379/24224022395.
López Coy M, Lozano Chávez DP, Ruiz Castillo D. Escalas de uso prehospitalario y hospitalario en sospecha diagnóstica de un accidente cerebrovascular en adultos: revisión de la literatura [Tesis de pregrado]. [Bogotá, Colombia]: Universidad El Bosque; 2020. http://hdl.handle.net/20.500.12495/7559
Salas Martínez NM, Lam Mosquera IE, Sornoza Moreira KM, Cifuentes Casquete KK. Evento cerebrovascular isquémico vs. hemorrágico. Recimundo. 2019;3(4):177-93. https://doi.org/10.26820/recimundo/3.(4).diciembre.2019.177-193
Savia A. Nuevas perspectivas en el manejo prehospitalario del accidente cerebrovascular. Neurol Argent. 2020;12(4):260-70. https://doi.org/10.1016/j.neuarg.2020.07.004
Barthels D, Das H. Current advances in ischemic stroke research and therapies. Biochim Biophys Acta Mol Basis Dis. 2020;1866(4):165260. https://doi.org/10.1016/j.bbadis.2018.09.012
Vacca V. Accidente isquémico transitorio: la importancia de seguir los consejos. Nursing. 2015;32(1):38-43. https://doi.org/10.1016/j.nursi.2015.02.010
Tejada Meza H, Saldaña Inda I, Serrano Ponz M, Ara JR, Moreno JM. Impacto en los tiempos puerta-aguja de un conjunto de medidas para optimizar la atención hospitalaria del código ictus. Neurología. 2020;38(3):141-9. https://doi.org/10.1016/j.nrl.2020.07.023
Brunser AM, Mazzon E, Muñoz P, Hoppe A, Lavados PM, Rojo A, et al. Determinantes del tiempo puerta-aguja en trombólisis endovenosa en el infarto cerebral, experiencia de un centro. Rev Méd Chile. 2020;148(8):1090-5. https://doi.org/10.4067/S0034-98872020000801090
Iglesias-Mohedano AM, García-Pastor A, Díaz-Otero F, Vázquez-Alen P, Martín-Gómez MA, Simón-Campo P, et al. A new protocol reduces median door-to-needle time to the benchmark of 30 minutes in acute stroke treatment. Neurología. 2021;36(7):487-94. https://doi.org/10.1016/j.nrl.2018.04.001
Ajmi SC, Advani R, Fjetland L, Kurz KD, Lindner T, Qvindesland SA, et al. Reducing door-to-needle times in stroke thrombolysis to 13 min through protocol revision and simulation training: a quality improvement project in a Norwegian stroke centre. BMJ Qual Saf. 2019;28(11):939-48. https://doi.org/10.1136/bmjqs-2018-009117
Triana JD, Becerra GP. Tiempo puerta-TAC antes y después de la implementación de una vía clínica para la atención de los pacientes que ingresan con diagnóstico de ACV isquémico hiperagudo al servicio de urgencias del Hospital de San José. Acta Neurol. Colomb. 2015;31(2):134-140. https://repositorio.fucsalud.edu.co/handle/001/1750
Coronel Gaviria A, Chilito PA, Cabrera-Velasco CE, Zamora-Bastidas T, Vargas Uricoechea H. Trombólisis endovenosa en ACV isquémico: experiencia en un hospital de Popayán, Cauca. Acta Neurol Colomb. 2020;36(1):11-17. https://doi.org/10.22379/24224022272.
Rose D, Cavalier A, Kam W, Cantrell S, Lusk J, Schrag M, et al. Complications of intravenous tenecteplase versus alteplase for the treatment of acute ischemic stroke: a systematic review and meta-analysis. Stroke. 2023;54(5):1192-1204. https://doi.org/10.1161/strokeaha.122.042335
Torres Zafra JF, Pérrez Romero GE. Eficacia y seguridad del tenecteplase en el tratamiento del ACV isquémico agudo. Acta Neurol Colomb. 2020;36(2):110-5. https://doi.org/10.22379/24224022286
Greenberg SM, Ziai WC, Cordonnier C, Dowlatshahi D, Francis B, Goldstein JN, et al. 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke. 2022;53(7):e282-361. https://doi.org/10.1161/STR.0000000000000407
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.